22 Oct 2009

Interim Report - Promising early results for UCB's new products

Read More
5 Oct 2009

Cimzia®, the only PEGylated anti-TNF, approved in Europe and available in a syringe designed in partnership with OXO Good Grips®

Read More
1 Oct 2009

UCB announces convertible bond offering increased to EUR 500 million following exercise of over-allotment option

Read More
30 Sep 2009

UCB successfully completes its convertible bond offering

Read More
30 Sep 2009

UCB announces an increase in the amount of the issuance of its convertible bond offering to up to EUR 450 million

Read More
30 Sep 2009

UCB launches an offer of up to EUR 350 million convertible bonds, due 2015

Read More
28 Sep 2009

UCB and AstraZeneca form alliance for the commercialization of Cimzia® in Brazil

Read More
27 Aug 2009

UCB and Immunomedics announce positive results for epratuzumab phase IIb study in systemic lupus erythematosus (SLE)

Read More
24 Aug 2009

UCB and Novartis to expand cooperation in Germany

Read More
12 Aug 2009

UCB and its design partners, OXO® and Smart Design, win 2009 "Red Dot: Communication Design"

Read More
Subscribe to